Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool

International Journal of STD and AIDS

Volumn 14, Issue 6, 2003, Pages 379-385

  Corkill, J E ^a   Komolafe, A J ^a   Neal, T J ^a   Mortimore, A ^a   Alawattegama, A B ^a   Hart, C A ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Ciprofloxacin resistant; Molecular epidemiology; N. gonorrhoeae

Indexed keywords

BACTERIAL DNA; BETA LACTAMASE; CEFTRIAXONE; CIPROFLOXACIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CLONING; DNA FINGERPRINTING; ENDEMIC DISEASE; GENE AMPLIFICATION; GENOTYPE; GONORRHEA; GYRA GENE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NEISSERIA GONORRHOEAE; OPA GENE; PARC GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUALITY; TRAVEL; UNITED KINGDOM; VIRULENCE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CEFTRIAXONE; CIPROFLOXACIN; DNA FINGERPRINTING; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDEMIC DISEASES; ENGLAND; EPIDEMIOLOGY, MOLECULAR; FEMALE; GONORRHEA; HUMANS; MALE; MEDICAL HISTORY TAKING; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEROTYPING;

EID: 0038388185     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203765371259     Document Type: Article

References (27)

1. Ashford WA, Golash RG, Hemming UG. Penicillinase-producing Neisseria gonorrhoeae. Lancet 1976;2:657-8
2. Percival A, Rowlands J, Corkill JE, et al. Penicillinase-producing gonococci in Liverpool. Lancet 1976;2:1379-82
3. King A, Phillips I. The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother 1986;18(Suppl):1-20
4. Latif AS. Management of STI at the primary health care level. In: Arya OP, Hart CA, eds. Sexually transmitted infections and AIDS in the tropics. New York: CABI Publishing, 1998:299-319
5. Gransden WR, Warren CA, Phillips I, Hodges M, Barlow D. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin (Letter). Lancet 1990;335:51
6. Turner A, Jephcott AE, Haji TC, Gupta PC. Ciprofloxacin resistant Neisseria gonorrhoeae. Genitourin Med 1990;66:43
7. O'Mahony C, Timmins D. Treatment failure using double dose ciprofloxacin in case of highly resistant gonorrhoea. Genitourin Med 1992;68:274-5
8. Birley H, MacDonald P, Carey P, Fletcher J. High level ciprofloxacin resistance in Neisseria gonorrhoeae. Genitourin Med 1994;70:292-3
9. Deguchi T, Yasuda M, Asano M, et al. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1995;39:561-63
10. Deguchi T, Yasuda M, Nakano M, et al. Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones. J Clin Microbiol 1997;35:948-50
11. Palmer HM, Leeming JP, Turner A. Investigation of an outbreak of ciprofloxacin-resistant Neisseria gonorrhoeae using a simplified opa-typing method. Epidemiol Infect 2001;126:219-24
12. O'Rourke M, Ison CA, Renton AM, Spratt BG. Opa-typing: a high resolution tool for studying the epidemiology of gonorrhoea. Mol Microbiol 1995;17:865-75
13. Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. Antimicrobial sensitivity testing guidelines. Birmingham, UK: British Society for Antimicrobial Chemotherapy, 1998
14. Turner A, Jephcott AE, Gough KR. Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae. J Clin Pathol 1991;44:169-70
15. Knapp JS, Hale JA, Neal SW, Wintersheid K, Rice RJ, Whittington WL. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob Agents Chemother 1995;39:2442-5
16. Willmott CJR, Maxwell A. A single point mutation in the DNA gyrase protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob Agents Chemother 1993;37:126-7
17. Belland RJ, Morrison SG, Ison C, Huang WM. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 1994;14:371-80
18. Gonzalez I, Georgiou M, Alcaide F, Balas D, Linares J, De La Campa AG. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci. Antimicrob Agents Chemother 1998;42:2792-8
19. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9
20. Gordon SM, Carlyn CJ, Doyle LJ, et al. The emergence of Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in Cleveland, Ohio: epidemiology and risk factors. Ann Intern Med 1996;125:465-70
21. Camarena JJ, Nogueira JM, Dasi MA, et al. DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains. Sex Transm Dis 1995;22:128-36
22. Van Looveren M, Ison CA, Ieven M, et al. Evaluation of the discriminatory power of typing methods for Neisseria gonorrhoeae. J Clin Microbiol 1999;37:2183-8
23. Viscidi RP, Demma JC, Gu J, Zenilman J. Comparison of sequencing of the por gene and typing of the opa gene for discrimination of Neisseria gonorrhoeae strains from clinical contacts. J Clin Microbiol 2000;38:4430-8
24. Tayal SC, Sankar KN, Pattman RS, Watson PG, Galloway A. Neisseria gonorrhoeae in Newcastle upon Tyne 1995-1997: increase in ciprofloxacin resistance. Int J STD AIDS 1999;10:290-3
25. Nwokolo NC, Boag FC. Antibiotic-resistant gonorrhoea in a London GUM clinic. Int J STD AIDS 2002;13:137-8
26. Su X, Lind I. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998. Antimicrob Agents Chemother 2001;45:117-23
27. Normark S, Albiger B, Jonsson A-B. Gonococci cause immunosuppression by engaging a coinhibitory receptor on T lymphocytes. Natur Immun 2002;3:210-11